These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 19567655)

  • 41. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator.
    Dougherty CM; Lewis FM; Thompson EA; Baer JD; Kim W
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1594-602. PubMed ID: 15613121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
    Henyan NN; White CM; Gillespie EL; Smith K; Coleman CI; Kluger J
    J Intern Med; 2006 Nov; 260(5):467-73. PubMed ID: 17040253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Comparison of ICD implantations in the United States versus Italy.
    Greenberg SM; Epstein AE; Deering T; Goldman DS; Ghidina M; Neason C; Proclemer A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S143-6. PubMed ID: 17302692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Iles L; Pfluger H; Lefkovits L; Butler MJ; Kistler PM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2011 Feb; 57(7):821-8. PubMed ID: 21310318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.
    Alter P; Waldhans S; Plachta E; Moosdorf R; Grimm W
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):926-32. PubMed ID: 16176531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atrial tachyarrhythmias in primary and secondary prevention ICD recipients: clinical and prognostic data.
    Botto GL; Luzi M; Ruffa F; Russo G; Ferrari G
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S48-53. PubMed ID: 17169133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community.
    Narayanan K; Reinier K; Uy-Evanado A; Teodorescu C; Chugh H; Marijon E; Gunson K; Jui J; Chugh SS
    Circulation; 2013 Oct; 128(16):1733-8. PubMed ID: 24048201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of Wedensky Modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter-defibrillator.
    Elgarhi N; Kreuz J; Balta O; Nickenig G; Hoium H; Lewalter T; Schwab JO
    Heart; 2008 Apr; 94(4):e16. PubMed ID: 17639096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implantable cardioverter-defibrillators in patients with left ventricular noncompaction.
    Kobza R; Jenni R; Erne P; Oechslin E; Duru F
    Pacing Clin Electrophysiol; 2008 Apr; 31(4):461-7. PubMed ID: 18373765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Gravelin LM; Yuhas J; Remetz M; Radford M; Foley J; Lampert R
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):152-6. PubMed ID: 21304093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival in octogenarians receiving implantable defibrillators.
    Koplan BA; Epstein LM; Albert CM; Stevenson WG
    Am Heart J; 2006 Oct; 152(4):714-9. PubMed ID: 16996846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience.
    Curnis A; Mascioli G; Bontempi L; Cerini M; Bignotti T; Bonetti G; Dei Cas L
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1241-5. PubMed ID: 19001931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.